Dr. Spiegel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 elm st
Westfield, NJ 07090- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Medical Oncology, 1977 - 1979
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1974 - 1977
- Perelman School of Medicine at the University of PennsylvaniaClass of 1975
- Yale UniversityB.A.
Certifications & Licensure
- NY State Medical License 1976 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsEmvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia.Arthur Branstrom, Liangxian Cao, Bansri Furia, Christopher Trotta, Marianne Santaguida, Jason D Graci, Joseph M Colacino, Balmiki Ray, Wencheng Li, Josephine Sheedy, A...> ;Frontiers in Oncology. 2022 Jan 1
- 12 citationsPreclinical and Early Clinical Development of PTC596, a Novel Small-Molecule Tubulin-Binding Agent.Finith Jernigan, Arthur Branstrom, John D. Baird, Liangxian Cao, Mandar V. Dali, Bansri Furia, Min Jung Kim, Kylie O'Keefe, Ronald Kong, Oscar L. Laskin, Joseph M. Col...> ;Molecular Cancer Therapeutics. 2021 Jul 26
- 289 citationsAtaluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialCraig M. McDonald, Craig Campbell, Ricardo Erazo Torricelli, Richard S. Finkel, Kevin M. Flanigan, Nathalie Goemans, Peter Heydemann, Anna Kamińska, Janbernd Kirschner...> ;Lancet. 2017 Sep 23
- Join now to see all
Press Mentions
- Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of DirectorsAugust 4th, 2020
- What Will Happen to Cyclacel Pharmaceuticals, Inc. (CYCCP) Next? The Stock Formed a Several Months Descending Triangle PatternMarch 12th, 2019
- Edge Therapeutics Enters into Merger Agreement with PDS Biotechnology to Form Clinical-Stage Cancer Immunotherapy CompanyDecember 8th, 2018
- Join now to see all
Professional Memberships
- Member
Industry Relationships
- Chief Medical Officer, Schering Plough1984 - 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: